3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Biphenotypic, Acute
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Leukemia, Myeloid, Accelerated Phase
4
Blast Crisis
4
Down Syndrome
3
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Urinary Bladder Neoplasms
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mouth Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
51
fludarabine
37
Dexamethasone
35
venetoclax
30
pembrolizumab
25
Rituximab
20
pomalidomide
18
Lenalidomide
17
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
12
carfilzomib
11
Temozolomide
11
Injections
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Cisplatin
9
Bortezomib
9
Azacitidine
9
selinexor
8
Vincristine
8
Immunotherapy, Adoptive
8
obinutuzumab
7
cemiplimab
7
Drug Therapy
7
Carboplatin
7
zanubrutinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
merphos
×
1 year
×
Clear all
No trials found.